- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Liquidia Corporation (LQDA)
Track today's live Liquidia (LQDA) share price, performance and key data on this page with our current NASDAQ:LQDA stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Liquidia share price on the NASDAQ exchange. Use the dropdown to switch exchange for the LQDA share price, head to our technical summary section, which provides analysis on Liquidia share price buy/sell indicators using real-time data (or discuss the Liquidia (LQDA) stock price today with other investors in the Liquidia NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:LQDA share price (ISIN: US53635D2027) to enhance your trading decisions with our free investment tools and resources.
What Is the Liquidia Corporation Share Price Today?
The Liquidia share price today is 58.120.
What Is the Stock Symbol for Liquidia Corporation
The stock symbol (or 'ticker') for Liquidia Corporation is "LQDA."
What Stock Exchange Does Liquidia Corporation Trade On?
Liquidia Corporation is listed and trades on the NASDAQ stock exchange.
Is Liquidia Corporation a Good Stock to Buy?
Determining whether Liquidia (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:LQDA share price (ISIN: US53635D2027) to enhance your trading decisions with our free investment tools and resources.
What Is the Liquidia Corporation Share Price Today?
The Liquidia share price today is 58.120.
What Is the Stock Symbol for Liquidia Corporation
The stock symbol (or 'ticker') for Liquidia Corporation is "LQDA."
What Stock Exchange Does Liquidia Corporation Trade On?
Liquidia Corporation is listed and trades on the NASDAQ stock exchange.
Is Liquidia Corporation a Good Stock to Buy?
Determining whether Liquidia (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
54.010
58.740
52 wk Range
22.310
93.610
LQDA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
54.01058.740
52 wk Range
22.31093.610
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LQDA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
60.750
Upside
+4.53%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 60.750
(+4.53% Upside)
Liquidia Corporation Earnings Call Summary for Q3/2026
- Q3 revenue hit $225.3M, beating estimates by 5.2%; YUTREPIA sales surged 31% sequentially to $222.7M with strong PAH adoption momentum.
- Posted $2.64 EPS loss vs. $0.90 profit forecast due to $389.7M one-time United Therapeutics patent settlement charge through April 2027.
- Adjusted EBITDA rose to $140.5M for fifth straight quarter; gross margin held at 94% while SG&A fell to 26% of revenue, showing operating leverage.
- Settlement removes litigation overhang but limits YUTREPIA label to PAH only; company says no capital raise needed to fund operations and payments.
- October shipments reached record highs post-settlement; formal 2027 guidance delayed to January with SPRINT study launch expected by end of 2026.
Last Updated: 10/11/2026, 14:36
Read Full TranscriptEarnings
Latest Release
10/11/2026
EPS / Forecast
-2.64 / 0.90
Revenue / Forecast
225.3M / 214.18M
Compare LQDA to Peers and Sector
Metrics to compare | LQDA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLQDAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −55.6x | 5.0x | −0.2x | |
PEG Ratio | −2.19 | −0.18 | 0.00 | |
Price/Book | −205.7x | 2.4x | 2.6x | |
Price / LTM Sales | 8.4x | 2.0x | 2.8x | |
Upside (Analyst Target) | 4.5% | 84.2% | 60.5% | |
Fair Value Upside | Unlock | 16.3% | 7.8% | Unlock |
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company’s lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil which is in phase III clinical trial for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). In addition, the company offers PRINT technology which allows to engineer and manufacture uniform drug particles with precise control over the size, three-dimensional geometric shape, and chemical composition of the particles. It has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD; Vectura; The University of North Carolina at Chapel Hill; GlaxoSmithKline; Alcon Inc; and promotion Agreement with Sandoz. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Liquidia (NASDAQ: LQDA) Share Price Today?
The Liquidia stock price today is 58.120 USD.
What Stock Exchange Does Liquidia (LQDA) Trade On?
Liquidia is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Liquidia?
The stock symbol (also called a 'ticker') for Liquidia is "LQDA."
What Is the Current Liquidia Market Capitalisation?
As of today, Liquidia (NASDAQ: LQDA) market cap is 5.240B USD.
What Is Liquidia's (LQDA) Earnings Per Share (TTM)?
The Liquidia EPS is currently -1.07 (Trailing Twelve Months).
When Is the Next Liquidia Earnings Date?
Liquidia's next earnings report will be released on 18/03/2027.
Is LQDA a Buy or Sell From a Technical Analyst Perspective?
Based on today's Liquidia moving averages and other technical indicators, the daily buy/sell signal for LQDA stock is Strong Buy.
How Many Times Has Liquidia Stock Split?
Liquidia has split 0 times. (See the LQDA stock split history page for full effective split date and price information.)
How Many Employees Does Liquidia Have?
Liquidia has 216 employees, based on their latest Companies House report.
What is the current trading status of Liquidia (NASDAQ: LQDA)?
As of 12/11/2026, Liquidia (LQDA) is trading at a share price of 58.120 USD, with a previous close of 55.210 USD. The stock has fluctuated within a day range of 54.010 USD to 58.740 USD, while its 52-week range spans from 22.310 USD to 93.610 USD.
What Is Liquidia (LQDA) Price Target According to Analysts?
The average 12-month price target for Liquidia is 60.750 USD, with a high estimate of 77 USD and a low estimate of 33 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +4.53% Upside potential.
What Is the LQDA Premarket Price?
LQDA's last pre-market stock price is 55.480 USD. The pre-market share volume is 2,810.000, and the stock has decreased by 0.270, or 0.490%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.